Neuro-Oncology Reviews

Volume 25 Number 15
15 August 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 15, 15 August

Burge C, Vanguru V, Ho PJ.
Chimeric antigen receptor T-cell therapy.
Aust Prescr. 2023 Aug;46(2):36-39. doi: 10.18773/austprescr.2023.003. PMID: 38053567. Review.

Hsia T, Small JL, Yekula A, Batool SM, Escobedo AK, Ekanayake E, You DG, Lee H, Carter BS, Balaj L.
Systematic Review of Photodynamic Therapy in Gliomas.
Cancers (Basel). 2023 Aug 1;15(15):3918
. doi: 10.3390/cancers15153918. PMID: 37568734. Review. ˍ

Thomas BC, Staudt DE, Douglas AM, Monje M, Vitanza NA, Dun MD.
CAR T cell therapies for diffuse midline glioma.
Trends Cancer. 2023 Aug 2:S2405-8033(23)00134-6. doi: 10.1016/j.trecan.2023.07.007. PMID: 37541803. Review. ˍ

Bashir F, Qureshi BM, Minhas K, Tabori U, Bouffet E, Hawkins C, Enam A, Mushtaq N.
Pakistan National Guidelines for Pediatric High-Grade Gliomas.
Pak J Med Sci. 2023 Aug 3;39(5):1548-1554
. doi: 10.12669/pjms.39.5.6300. PMID: 37680835. Guidelines. ˍ

Li G, Xu X, Cui J, Zhang F, Wang S.
Efficacy of apatinib combined with temozolomide in the treatment of recurrent high-grade glioma: A meta-analysis.
Exp Ther Med. 2023 Aug 3;26(3):452. doi: 10.3892/etm.2023.12151
. PMID: 37614429. Meta-analysis. ˍ

Mentis AA, Papavassiliou KA, Piperi C, Papavassiliou AG.
How can cancer research be illuminated by brain research (and vice versa)?
Int J Cancer. 2023 Aug 3
. doi: 10.1002/ijc.34682. PMID: 37534858. Perspective˰ ˍ

Kao TJ, Lin CL, Yang WB, Li HY, Hsu TI.
Dysregulated lipid metabolism in TMZ-resistant glioblastoma: pathways, proteins, metabolites and therapeutic opportunities.
Lipids Health Dis. 2023 Aug 3;22(1):114. doi: 10.1186/s12944-023-01881-5. PMID: 37537607. Review. ˍ

Leary SES, Onar-Thomas A, Fangusaro J, Gottardo NG, Cohen K, Smith A, Huang A, Haas-Kogan D, Fouladi M; COG Central Nervous System Committee.
Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors.
Pediatr Blood Cancer. 2023 Aug 3:e30600
. doi: 10.1002/pbc.30600. PMID: 37534382. Guidelines˰ ˍ

Qi Y, Xiong W, Chen Q, Ye Z, Jiang C, He Y, Ye Q.
New trends in brain tumor immunity with the opportunities of lymph nodes targeted drug delivery.
J Nanobiotechnology. 2023 Aug 4;21(1):254. doi: 10.1186/s12951-023-02011-0. PMID: 37542241. Review. ˍ

Segura PP, Quintela NV, García MM, Del Barco Berrón S, Sarrió RG, Gómez JG, Castaño AG, Martín LMN, Rubio OG, Losada EP.
SEOM-GEINO clinical guidelines for high-grade gliomas of adulthood (2022).
Clin Transl Oncol. 2023 Aug 4;25(9):2634-2646
. doi: 10.1007/s12094-023-03245-y. PMID: 37540408. Guidelines. ˍ

Choi H, Kim TG, Jeun SS, Ahn S.
Human gamma-delta (γδ) T cell therapy for glioblastoma: A novel alternative to overcome challenges of adoptive immune cell therapy.
Cancer Lett. 2023 Aug 5:216335. doi: 10.1016/j.canlet.2023.216335. PMID: 37544475. Review˰ ˍ

Cecchi N, Romanelli R, Ricevuti F, Amitrano M, Carbone MG, Dinardo M, Burgio E.
Current knowledges in pharmaconutrition: "Ketogenics" in pediatric gliomas.
Front Nutr. 2023 Aug 8;10:1222908
. doi: 10.3389/fnut.2023.1222908. PMID: 37614745. Review. ˍ

Kas A, Rozenblum L, Pyatigorskaya N.
Clinical Value of Hybrid PET/MR Imaging: Brain Imaging Using PET/MR Imaging.
Magn Reson Imaging Clin N Am. 2023 Aug 8;31(4):591-604
. doi: 10.1016/j.mric.2023.06.004. PMID: 37741643. Review˰ ˍ

Prados MD.
Current Strategies for Management of Medulloblastoma.
Diagnostics (Basel). 2023 Aug 8;13(16):2622
. doi: 10.3390/diagnostics13162622. PMID: 37627881. Review. ˍ

Spallone A.
Editorial: Modern neurosurgical management of gliomas, including local therapies.
Front Oncol. 2023 Aug 8;13:1217180
. doi: 10.3389/fonc.2023.1217180. PMID: 37614507. Editorial. ˍ

Lin S, Li K, Qi L.
Cancer stem cells in brain tumors: From origin to clinical implications.
MedComm (2020). 2023 Aug 9;4(4):e341
. doi: 10.1002/mco2.341. PMID: 37576862. Review. ˍ

Farhat M, Fuller GN, Wintermark M, Chung C, Kumar VA, Chen M.
Multifocal and multicentric glioblastoma: Imaging signature, molecular characterization, patterns of spread, and treatment.
Neuroradiol J. 2023 Aug 10:19714009231193162
. doi: 10.1177/19714009231193162. PMID: 37559514. Review. ˍ

Mier-García JF, Ospina-Santa S, Orozco-Mera J, Ma R, Plaha P.
Supramaximal versus gross total resection in Glioblastoma, IDH wild-type and Astrocytoma, IDH-mutant, grade 4, effect on overall and progression free survival: systematic review and meta-analysis.
J Neurooncol. 2023 Aug 10
. doi: 10.1007/s11060-023-04409-0. PMID: 37561356. Review, Meta-analysis˰ ˍ

Parveen R, Harihar D, Chatterji BP.
Recent histone deacetylase inhibitors in cancer therapy.
Cancer. 2023 Aug 10. doi: 10.1002/cncr.34974. PMID: 37560925. Review˰ ˍ

In A, Stopa BM, Cuoco JA, Stump MS, Apfel LS, Rogers CM.
Central nervous system lymphoproliferative disorder secondary to methotrexate: A systematic literature review and case illustration.
World Neurosurg. 2023 Aug 12:S1878-8750(23)01120-8
. doi: 10.1016/j.wneu.2023.08.018. PMID: 37574195. Case report, Review˰ ˍ

Miguel Llordes G, Medina Pérez VM, Curto Simón B, Castells-Yus I, Vázquez Sufuentes S, Schuhmacher AJ.
Epidemiology, Diagnostic Strategies, and Therapeutic Advances in Diffuse Midline Glioma.
J Clin Med. 2023 Aug 12;12(16):5261
. doi: 10.3390/jcm12165261. PMID: 37629304. Review. ˍ

Price G, Rossitto C, Price H, Hadjipanayis C, Martini M.
Trends in Immunotherapy Clinical Trials to Treat Glioblastoma: A Look at Progress and Challenges.
World Neurosurg. 2023 Aug 12:S1878-8750(23)01121-X
. doi: 10.1016/j.wneu.2023.08.020. PMID: 37574192. Review˰ ˍ

Castresana JS, Meléndez B.
Glioblastoma Biology, Genetics and Possible Therapies.
Cells. 2023 Aug 14;12(16):2063
. doi: 10.3390/cells12162063. PMID: 37626873. Editorial. ˍ

Duan ZH, Wei ZL.
Research Progress in Immunotherapy of Gliomas.
J Integr Neurosci. 2023 Aug 14;22(5):118
. doi: 10.31083/j.jin2205118. PMID: 37735122. Review. ˍ

Heuer S, Winkler F.
Glioblastoma revisited: from neuronal-like invasion to pacemaking.
Trends Cancer. 2023 Aug 14:S2405-8033(23)00136-X
. doi: 10.1016/j.trecan.2023.07.009. PMID: 37586918. Perspective˰ ˍ

Wang JH, Kiess AP.
PSMA-targeted therapy for non-prostate cancers.
Front Oncol. 2023 Aug 14;13:1220586
. doi: 10.3389/fonc.2023.1220586. PMID: 37645427. Review. ˍ

Baddam S, Kalagara S, Krishna K, Enaganti S.
Recent advancements and theranostics strategies in glioblastoma therapy.
Biomed Mater. 2023 Aug 15
. doi: 10.1088/1748-605X/acf0ab. PMID: 37582381. Review˰ ˍ

Bel'skaya LV, Sarf EA, Loginova AI.
Diagnostic Value of Salivary Amino Acid Levels in Cancer.
Metabolites. 2023 Aug 15;13(8):950
. doi: 10.3390/metabo13080950. PMID: 37623893. Review. ˍ

Meenakshi S, Maharana KC, Nama L, Kumar VU, Dhingra S, Ravichandiran V, Murti K, Kumar N.
Targeting Histone 3 Variants Epigenetic Landscape and Inhibitory Immune Checkpoints: An Option for Paediatric Brain Tumours Therapy.
Curr Neuropharmacol. 2023 Aug 15
. doi: 10.2174/1570159X21666230809110444. PMID: 37605389. Review˰ ˍ


Shoaib F, Furrukh M, Mushtaq F, Sayeed S, Nasir H, Ghafoor H.
Extra Neural Metastasis Of Glioblastoma Multiforme: A Literature Review.
J Pak Med Assoc. 2023 Aug 15;73(9):1869-1873. doi: 10.47391/JPMA.7694. PMID: 37817700. Review.